We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

[F]oxymoron via Creative Commons

TCD among research group awarded €3m for anti-inflammatory project

The project will investigate the use of plants from the Amazon rainforest on immune processes.

AN INTERNATIONAL research project involving scientists at Trinity College Dublin has been awarded €3 million in EU funding to explore ways of tackling inflammatory diseases.

Scientists from research institutions and universities in Italy, Switzerland, Scotland, Dublin, and Brazil will work together on a new programme to explore ‘novel mechanisms of resolution in inflammation’.

TCD biochemistry professor Luke O’Neill will be studying plant-derived compounds sourced in the Amazon rainforest on innate immune processes. These immunity mechanisms are important for diseases such as rheumatoid arthritis and Type 2 diabetes.

O’Neill says the tropical plants have been identified by Brazilian scientists who are knowledgeable about herbal remedies used by native peoples in the Amazon. He said the plants “are showing promise for [tackling] inflammatory diseases”.

The funding has been awarded under the European Commission’s Seventh Framework Programme (FP7) and the overall project aims to cover related research from the discovery of natural compounds through to clinical trials.

Your Voice
Readers Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.